Oral Pathology in the Context of COVID-19: Perspectives Based on a Compilation of Literature Data

REFERENCES

• Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis 2020; May;94:44–48. doi:10.1016/j.ijid.2020.03.004. Epub 2020 Mar 12.
   Google Scholar
• Saxena S. Coronavirus disease-2019: A brief compilation of facts. J Oral Maxillofac Pathol 2020 Jan–Apr24(1):5. doi:10.4103/jomfp.JOMFP_137_20.
   Google Scholar
• Archived: WHO timeline — COVID-19. www.who.int/news-room/detail/27-04-2020-who-timeline—covid-19. Accessed June 22, 2020.
   Google Scholar
• World Health Organization. Coronavirus disease (COVID-19) dashboard. covid19.who.int. Accessed June 22, 2020.
   Google Scholar
• Dai X. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur J Prev Cardiol 2020 Apr 28;2047487320922370. doi: 10.1177/2047487320922370.
   Google Scholar
• Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe COVID-19 with respiratory failure. N Engl J Med June 2020:NEJMoa2020283. doi:10.1056/NEJMoa2020283.
   Google Scholar
• Wu R, Wang L, Kuo H-CD, et al. An update on current therapeutic drugs treating COVID-19. Curr Pharmacol Reports 2020 May 11;1-15. doi:10.1007/s40495-020-00216-7.
   Google Scholar
• Rabby MII. Current drugs with potential for treatment of COVID-19 : A literature review. J Pharm Pharm Sci 2020;23(1):58–64. doi: 10.18433/jpps31002.
   Google Scholar
• Henwood AF. Coronavirus disinfection in histopathology. J Histotechnol 2020 Jun;43(2):102–104. doi:10.1080/01478885.2020.1734718. Epub 2020 Mar 1.
   PubMed Web of Science ®Google Scholar
• Ansari R, Gheitani M, Heidari F, Heidari F. Oral cavity lesions as a manifestation of the novel virus (COVID 19): A letter to editor. Oral Dis 2020 Jun 8. doi: 10.1111/odi.13465. Online ahead of print.
   Google Scholar
• Chaux-Bodard A-G, Deneuve S, Desoutter A. Oral manifestation of COVID-19 as an inaugural symptom? J Oral Med Oral Surg 2020;26(2):18. doi:10.1051/mbcb/2020011.
   Google Scholar
• Jimenez Cauhe J, Ortega Quijano D, Carretero Barrio I, et al. Erythema multiforme like eruption in patients with COVID-19 infection: Clinical and histological findings. Clin Exp Dermatol 2020 May 9; 10.1111/ced.14281. doi: 10.1111/ced.14281. Online ahead of print.
   Google Scholar
• Martín Carreras Presas C, Amaro Sánchez J, López Sánchez AF, Jané Salas E, Somacarrera Pérez ML. Oral vesiculobullous lesions associated with SARS CoV 2 infection. Oral Dis 2020 May 5; 10.1111/odi.13382. doi: 10.1111/odi.13382. Online ahead of print.
   Google Scholar
• Amorim dos Santos J, Normando AGC, Carvalho da Silva RL, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis 2020 Aug;97:326–328. doi:10.1016/j.ijid.2020.06.012.
   PubMed Web of Science ®Google Scholar
• Soares C, Carvalho R, Carvalho K, Carvalho M, Almeida O. Letter to editor: Oral lesions in a patient with COVID-19. Med Oral Patol Oral y Cir Bucal 2020 Jul;25(4):e563–e564. doi:10.4317/medoral.24044.
   Web of Science ®Google Scholar
• Díaz Rodríguez M, Jimenez Romera A, Villarroel M. Oral manifestations associated to COVID-19. Oral Dis 2020; 10.1111/odi.13555. doi:10.1111/odi.13555.
   Google Scholar
• Brandâo TB, Gueiros LA, Melo TS, et al. Oral lesions in patients with SARS-CoV-2 infection: Could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol 2020;S2212–4403(20)31119-6. doi:10.1016/j.oooo.2020.07.014.
   Google Scholar
• de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016 Aug;14(8):523–534. doi:10.1038/nrmicro.2016.81.
   PubMed Web of Science ®Google Scholar
• Stadler K, Masignani V, Eickmann M, et al. SARS — beginning to understand a new virus. Nat Rev Microbiol 2003 Dec;1(3):209–218. doi:10.1038/nrmicro775.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012 Nov 8;367(19):1814–1820. doi:10.1056/NEJMoa1211721.
   Google Scholar
• Costa VG da, Lázaro M, Marielena M, Saivish V. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Arch Virol 2020 Jul;165(7):1517–1526. doi:10.1007/s00705-020-04628-0. Epub 2020 Apr 22.
   Web of Science ®Google Scholar
• Cheng VCC, Lau SKP, Woo PCY, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007 Oct;20(4):660–694. doi:10.1128/CMR.00023-07.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pneumonia of unknown cause - China. www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en. Accessed May 22, 2020.
   Google Scholar
• Tan W, Zhao X, Ma X, et al. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China. China CDC Wkly 2020;2(4):61–62. doi:10.46234/ccdcw2020.017.
   Google Scholar
• World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19). www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. Accessed May 22, 2020.
   Google Scholar
• Albini A, Di Guardo G, Noonan DMC, Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med 2020; 15(5):759–766. doi:10.1007/s11739-020-02364-6.
   Google Scholar
• Harmer D, Gilbert M, Borman R, Clark KL. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002 Dec 4;532(1-2):107–110. doi:10.1016/S0014-5793(02)03640-2.
   Google Scholar
• Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004 Jun;203(2):631–637. doi:10.1002/path.1570.
   PubMed Web of Science ®Google Scholar
• Lauer SA, Grantz KH, Bi Q, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med 2020 May 5;172(9):577–582. doi:10.7326/M20-0504. Epub 2020 Mar 10.
   Google Scholar
• Li L, Huang T, Wang Y, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta analysis. J Med Virol 2020 Jun;92(6):577–583. doi:10.1002/jmv.25757.
   PubMed Web of Science ®Google Scholar
• Yu X, Yang R. COVID-19 transmission through asymptomatic carriers is a challenge to containment. Influenza Other Respir Viruses 2020 Jul;14(4):474-475. doi:10.1111/irv.12743.
   PubMed Web of Science ®Google Scholar
• Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol 2020 Jul;92(7):797–806. doi:10.1002/jmv.25783. Epub 2020 Apr 1.
   PubMed Web of Science ®Google Scholar
• Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur Arch Otorhinolaryngol 2020 Aug;277(8):2251–2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
   PubMed Web of Science ®Google Scholar
• Lechien JR, Hsieh J, Barillari MR, et al. Patient-reported outcome questionnaires for the evaluation of olfactory and gustatory dysfunctions in COVID-19. Eur Arch Otorhinolaryngol 2020 Aug;277(8):2393–2394. doi: 10.1007/s00405-020-06083-8. Epub 2020 Jun 3.
   Web of Science ®Google Scholar
• Vaira LA, Salzano G, De Riu G. The importance of olfactory and gustatory disorders as early symptoms of coronavirus disease (COVID-19). Br J Oral Maxillofac Surg 2020 Jun;58(5):615–616. doi:10.1016/j.bjoms.2020.04.024.
   Web of Science ®Google Scholar
• Vaira LA, Hopkins C, Salzano G, et al. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Head Neck 2020 Jul;42(7):1560–1569. doi:10.1002/hed.26269.
   PubMed Web of Science ®Google Scholar
• Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: Possible Mechanisms and Implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(3):344–346. doi:10.1016/j.oooo.2020.06.016
   Google Scholar
• CDC Weekly C. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Wkly 2020;2(8):113–122. doi:10.46234/ccdcw2020.032. Epub 2020 May 21.
   Google Scholar
• Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020 Apr 10;77(6):1–9. doi: 10.1001/jamaneurol.2020.1127. Online ahead of print.
   Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 Apr;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
   PubMed Web of Science ®Google Scholar
• Pei G, Zhang Z, Peng J, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol 2020 Jun;31(6):1157–1165. doi:10.1681/ASN.2020030276. Epub 2020 Apr 28.
   PubMed Web of Science ®Google Scholar
• Amico FD, Baumgart DC, Danese S, Peyrin-biroulet L. Diarrhea during COVID-19 infection: Pathogenesis, epidemiology, prevention and management. Clin Gastroenterol Hepatol 2020 Jul;18(8)1663–1672. doi:10.1016/j.cgh.2020.04.001. Epub 2020 Apr 8.
   Google Scholar
• Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020 May;17(5):259–260. doi:10.1038/s41569-020-0360-5.
   PubMed Web of Science ®Google Scholar
• Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J Eur Acad Dermatol Venereol 2020 May;34(5):e212–e213. doi: 10.1111/jdv.16387.
   PubMed Web of Science ®Google Scholar
• Fernandez-Nieto D, Ortega-Quijano D, Jimenez-Cauhe J, et al. Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital. Clin Exp Dermatol 2020 May 8; 10.1111/ced.14277. doi: 10.1111/ced.14277. Online ahead of print.
   Google Scholar
• Galván Casas C, Català A, Carretero Hernández G, et al. Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020 Jul;183(1):71–77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID 19: A preliminary review of an emerging issue.]. Br J Dermatol July 2020:bjd.19264. doi:10.1111/bjd.19264. Published online ahead of print June 1, 2020.
   Google Scholar
• Sachdeva M, Gianotti R, Shah M, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. J Dermatol Sci 2020 May;98(2):75–81. doi:10.1016/j.jdermsci.2020.04.011. Epub 2020 Apr 29.
   PubMed Web of Science ®Google Scholar
• Lagziel T, Quiroga L, Ramos M, Hultman CS, Asif M. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN). Cureus 2020 May; 12(5):e8198. doi:10.7759/cureus.8198.
   Google Scholar
• Zhang J, Xie B, Hashimoto K. Current status of potential therapeutic candidates for the COVID–19 crisis. Brain Behav Immun 2020 Jul;87:59–73. doi:10.1016/j.bbi.2020.04.046.
   PubMed Web of Science ®Google Scholar
• de Melo Filho MR, da Silva CAD, da Rocha Dourado M, de Oliveira Pires MB, Pêgo SPB, de Freitas EM. Palate hyperpigmentation caused by prolonged use of the antimalarial chloroquine. Head Neck Pathol 2012 Mar;6(1):48–50. doi:10.1007/s12105-011-0288-5.
   Google Scholar
• de Andrade BAB, Padron-Alvarado NA, Muñoz-Campos EM, Morais TM de L, Martinez-Pedraza R. Hyperpigmentation of hard palate induced by chloroquine therapy. J Clin Exp Dent 2017 Dec;9(12):e1487–e1491. doi:10.4317/jced.54387.
   Google Scholar
• Gallo CB, Luiz AC, Ferrazzo KL, Migliari DA, Sugaya NN. Drug-induced pigmentation of hard palate and skin due to chronic chloroquine therapy: Report of two cases. Clin Exp Dermatol 2009 Oct;34(7):e266–e267. doi:10.1111/j.1365-2230.2008.03185.x. Epub 2009 May 5.
   Web of Science ®Google Scholar
• de Andrade BAB, Fonseca FP, Pires FR, et al. Hard palate hyperpigmentation secondary to chronic chloroquine therapy: Report of five cases. J Cutan Pathol 2013 Sep;40(9):833–838. doi:10.1111/cup.12182. Epub 2013 Jun 19.
   Web of Science ®Google Scholar
• Horta-Baas G. Chloroquine-induced oral mucosal hyperpigmentation and nail dyschromia. Reumatol Clin May–Jun 2018;14(3):177–178. doi:10.1016/j.reumae.2017.06.001.
   Google Scholar
• Tosios KI, Kalogirou EM, Sklavounou A. Drug-associated hyperpigmentation of the oral mucosa: Report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2018 Mar;125(3):e54–e66. doi:10.1016/j.oooo.2017.10.006.
   Web of Science ®Google Scholar
• Godinho GV, Paz ALLM, Araújo Gomes EPA, Garcia CL, Volpato LER. Extensive hard palate hyperpigmentation associated with chloroquine use. Br J Clin Pharmacol. April 2020:bcp.14313. doi:10.1111/bcp.14313.
   Google Scholar
• Bahloul E, Jallouli M, Garbaa S, et al. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: Prevalence, clinical features and risk factors: A cross-sectional study of 41 cases. Lupus 2017 Oct;26(12):1304–1308. doi: 10.1177/0961203317700486. Epub 2017 Mar 29.
   Web of Science ®Google Scholar
• Perricone C, Triggianese P, Bartoloni E, et al. The antiviral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun 2020 Jul;111:102468. doi:10.1016/j.jaut.2020.102468.
   PubMed Web of Science ®Google Scholar
• Bindakhil MA, Mupparapu M. Osteomyelitis of the mandible exhibiting features of medication-related osteonecrosis in a patient with history of tocilizumab treatment. J Orofac Sci 2018;10(1):53–55. doi: 10.4103/jofs.jofs_46_18.
   Google Scholar
• Bennardo F, Buffone C, Giudice A. New therapeutic opportunities for COVID-19 patients with tocilizumab: Possible correlation of interleukin-6 receptor inhibitors with osteonecrosis of the jaws. Oral Oncol 2020 Jul;106:104659. doi:10.1016/j.oraloncology.2020.104659. Epub 2020 Mar 21.
   PubMed Web of Science ®Google Scholar
• Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020 May;18(5):1094–1099. doi:10.1111/jth.14817. Epub 2020 Apr 27.
   PubMed Web of Science ®Google Scholar
• University of Oxford. Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19. www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19.
   Google Scholar
• Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020 Jun;178:104787. doi:10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
   PubMed Web of Science ®Google Scholar
• Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med 2020 Jun;382(24):2327–2336. doi:10.1056/NEJMoa2007016.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang D, Du G, et al. Remdesivir in adults with severe COVID-19: A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2020 May 16;395(10236):1569–1578. doi:10.1016/S0140-6736(20)31022-9.
   PubMed Web of Science ®Google Scholar
• Wolff A, Joshi RK, Ekström J, et al. A guide to medications inducing salivary gland dysfunction, xerostomia and subjective sialorrhea: A systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D 2017 Mar;17(1):1–28. doi:10.1007/s40268-016-0153-9.
   PubMed Web of Science ®Google Scholar
• Uğur , Cahit K. Prednisolone-induced hairy tongue: A case report. Arch Rheumatol 2019 Feb 1;34(3):348–351. doi:10.5606/ArchRheumatol.2019.7239. eCollection 2019 Sep.
   Web of Science ®Google Scholar
• Assery MA. Efficacy of artificial salivary substitutes in treatment of xerostomia: A systematic review. J Pharm Bioallied Sci 2019 Feb;11(Suppl 1):S1–S12. doi:10.4103/JPBS.JPBS_220_18.
   Google Scholar
• Villa A, Wolff A, Aframian D, et al. World Workshop on Oral Medicine VI: A systematic review of medication-induced salivary gland dysfunction: Prevalence, diagnosis and treatment. Clin Oral Investig 2015 Sep;19(7):1563– 1580. doi:10.1007/s00784-015-1488-2. Epub 2015 May 22.
   PubMed Web of Science ®Google Scholar
• Ellepola AN, Samaranayake LP. Inhalational and topical steroids and oral candidosis: A mini review. Oral Dis 2001 Jul;7(4):211–6. doi:10.1034/j.1601-0825.2001.70402.x.
   Web of Science ®Google Scholar
• Thompson DF, Kessler TL. Drug-induced black hairy tongue. Pharmacotherapy 2010 Jun;30(6):585–593. doi:10.1592/phco.30.6.585.
   Web of Science ®Google Scholar
• Khurshid Z, Asiri FYI, Al Wadaani H. Human saliva: Noninvasive fluid for detecting novel coronavirus (2019-nCoV). Int J Environ Res Public Health 2020 Mar 26;17(7):2225. doi:10.3390/ijerph17072225.
   Web of Science ®Google Scholar
• To KK-W, Tsang OT-Y, Leung W-S, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect Dis 2020 May;20(5):565–574. doi:10.1016/S1473-3099(20)30196-1.
   PubMed Web of Science ®Google Scholar
• To KK-W, Tsang OT-Y, Yip CC-Y, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020 Jul 28;71(15):841–843. doi:10.1093/cid/ciaa149.
   Google Scholar
• Williams E, Bond K, Zhang B, Putland M, Williamson DA. Saliva as a non-invasive specimen for detection of SARS-CoV-2. J Clin Microbiol 2020 Jul 23;58(8)e00776-20. doi:10.1128/JCM.00776-20. Print 2020 Jul 23.
   Google Scholar
• Azzi L, Carcano G, Gianfagna F, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect 2020 Jul;81(1):e45–e50. doi:10.1016/j.jinf.2020.04.005. Epub 2020 Apr 14.
   PubMed Web of Science ®Google Scholar
• Pasomsub E, Watcharananan SP, Boonyawat K, et al. Saliva sample as a noninvasive specimen for the diagnosis of coronavirus disease 2019: A cross-sectional study. Clin Microbiol Infect 2020 May 15;S1198-743X(20)30278-0. doi: 10.1016/j.cmi.2020.05.001. Online ahead of print.
   Google Scholar
• Chen JH-K, Yip CC-Y, Poon RW-S, et al. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerg Microbes Infect 2020 Dec;9(1):1356–1359. doi:10.1080/22221751.2020.1775133.
   PubMed Web of Science ®Google Scholar
• Kam K, Yung CF, Maiwald M, et al. Clinical utility of buccal swabs for severe acute respiratory syndrome coronavirus 2 detection in coronavirus disease 2019 — infected children. J Pediatric Infect Dis Soc 2020 Jul 13;9(3):370–372. doi:10.1093/jpids/piaa068.
   Web of Science ®Google Scholar
• Henrique Braz-Silva P, Pallos D, Giannecchini S, To KK. SARS-CoV 2: What can saliva tell us? Oral Dis 2020;(April):odi.13365. doi:10.1111/odi.13365.
   Google Scholar
• Han P, Ivanovski S. Saliva — Friend and foe in the COVID-19 outbreak. Diagnostics (Basel) 2020 May 9;10(5):290. doi:10.3390/diagnostics10050290.
   Google Scholar
• Alizargar J, Etemadi Sh M, Aghamohammadi M, Hatefi S. Saliva samples as an alternative for novel coronavirus (COVID–19) diagnosis. J Formos Med Assoc 2020 Jul;119(7):1234-1235. doi:10.1016/j.jfma.2020.04.030.
   Web of Science ®Google Scholar
• Ceron JJ, Lamy E, Martinez-Subiela S, et al. Use of saliva for diagnosis and monitoring the SARS-CoV-2: A general perspective. J Clin Med 2020 May 15;9(5):1491. doi:10.3390/jcm9051491.
   Web of Science ®Google Scholar
• Xu R, Cui B, Duan X, Zhang P, Zhou X, Yuan Q. Saliva: Potential diagnostic value and transmission of 2019–nCoV. Int J Oral Sci 2020;12(1):9. doi:10.1038/s41368–020-0080-z.
   Google Scholar
• Sri Santosh T, Parmar R, Anand H, Srikanth K, Saritha M. A review of salivary diagnostics and its potential implication in detection of COVID-19. Cureus 2020 Apr 17;12(4):e7708. doi:10.7759/cureus.7708.
   Web of Science ®Google Scholar
• Winter L. First saliva test for COVID–19 approved for emergency use by FDA. www.the-scientist.com/news-opinion/first-saliva-test-for-covid-19-approved-for-emergency-use-by-fda-67416. Apr 14, 2020. Accessed May 25, 2020.
   Google Scholar
• Sharma S, Kumar V, Chawla A, Logani A. Rapid detection of SARS CoV 2 in saliva: Can an endodontist take the lead in point of care COVID-19 testing? Int Endod J 2020 Jul;53(7):1017–1019. doi:10.1111/iej.13317. Epub 2020 May 17.
   Web of Science ®Google Scholar
• Song J, Li Y, Huang X, et al. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS CoV 2. J Med Virol 2020 May 22; 10.1002/jmv.26045. doi: 10.1002/jmv.26045. Online ahead of print.
   Google Scholar
• Sabino-Silva R, Carolina A, Jardim G, Siqueira WL. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis. Clin Oral Investig 2020 Apr;24(4):1619–1621. doi: 10.1007/s00784-020-03248-x. Epub 2020 Feb 20.
   PubMed Web of Science ®Google Scholar
• Harrel SK, Molinari J. Aerosols and splatter in dentistry. J Am Dent Assoc 2004 Apr;135(4):429–437. doi:10.14219/jada.archive.2004.0207.
   PubMed Web of Science ®Google Scholar
• Coulthard P. Dentistry and coronavirus (COVID-19) — moral decision-making. Br Dent J 2020 Apr;228(7):503-505. doi:10.1038/s41415-020-1482-1.
   PubMed Web of Science ®Google Scholar
• Ge Z, Yang L, Xia J, Fu X, Zhang Y. Possible aerosol transmission of COVID-19 and special precautions in dentistry. J Zhejiang Univ B 2020 May;21(5):361–368. doi:10.1631/jzus.B2010010.
   PubMed Web of Science ®Google Scholar
• van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 2020 Apr 16;382(16):1564–1567. doi:10.1056/NEJMc2004973.
   PubMed Web of Science ®Google Scholar
• Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020 Mar;104(3):246–251. doi:10.1016/j.jhin.2020.01.022.
   PubMed Web of Science ®Google Scholar
• Chen J. Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect 2020 Mar;22(2):69–71. doi:10.1016/j.micinf.2020.01.004.
   PubMed Web of Science ®Google Scholar
• Darnell MER, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods 2004 Oct;121(1):85–91. doi:10.1016/j.jviromet.2004.06.006.
   PubMed Web of Science ®Google Scholar
• Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections. medRxiv 2020:2020.04.17.20058545. http://doi.org/10.1101/2020.04.17.20058545.
   Google Scholar
• Arduino PG, Conrotto D, Broccoletti R. The outbreak of novel coronavirus disease (COVID 19) caused a worrying delay in the diagnosis of oral cancer in northwest Italy: The Turin Metropolitan Area experience. Oral Dis 2020 Apr 19; 10.1111/odi.13362. doi: 10.1111/odi.13362. Online ahead of print.
   Google Scholar
• Villa A, Sankar V, Shiboski C. Tele(oral)medicine: BA new approach during the COVID-19 crisis. Oral Dis 2020 Apr 20; 10.1111/odi.13364. doi: 10.1111/odi.13364. Online ahead of print.
   Google Scholar
• Georgakopoulou EA. Digitally aided telemedicine during the SARS CoV 2 pandemic to screen oral medicine emergencies. Oral Dis 2020 May 5; 10.1111/odi.13383. doi: 10.1111/odi.13383. Online ahead of print.
   Google Scholar